Digital Pulse

Artificial intelligence (AI) is now making waves in the pharmaceutical and life sciences industry. Healthcare leaders are now dealing with the question: How can AI make patient outcomes better without losing sight of the people it’s designed to serve? In the recent episode of Digital Pulse by Pharmatica, host Shubhangi Dua, Podcast Producer and B2B Journalist , sat down with Kate O’Reilly, Preside...

Pharma leaders are investing a lot in large language models (LLMs) for issues that a simpler, cheaper machine learning model could handle more quickly and validate with less effort. This is the warning from Lara Masad, an AI and Data Innovation independent consultant , who spoke on the Pharmatica podcast hosted by Shubhangi Dua. The main issue, according to Masad, is that the industry confuses two...

A product receives market authorisation. It is clinically validated, commercially ready, and genuinely needed. Then it waits for a guideline review, cost evaluation, formulary decisions and three years later, it reaches an NHS patient. For pharma executives who have spent a decade developing that product, the timeline is not a surprise. But it is increasingly a choice, not an inevitability. Judit...

Across many parts of Africa, clinical research still depends heavily on paper-based workflows. For pharmaceutical companies managing global trial portfolios, this can create operational challenges around data quality, monitoring, and regulatory readiness, particularly when studies contribute to submissions in the US and Europe. Adriaan Kruger, founder and CEO of nuvoteQ has spent twelve years buil...